Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 951 to 1000 of 2013

TitleReference numberPublishedLast updated
Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancerTA595
Endovascular insertion of an intrasaccular wire-mesh blood-flow disruption device for intracranial aneurysmsHTG524
Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolismNG89
Alcohol interventions in secondary and further educationNG135
PICO negative pressure wound dressings for closed surgical incisionsHTG509
Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitisTA590
Letermovir for preventing cytomegalovirus disease after a stem cell transplantTA591
Chronic obstructive pulmonary disease in over 16s: diagnosis and managementNG115
End of life care for infants, children and young people with life-limiting conditions: planning and managementNG61
Nusinersen for treating spinal muscular atrophyTA588
Blinatumomab for treating acute lymphoblastic leukaemia in remission with minimal residual disease activityTA589
Transurethral laser ablation for recurrent non-muscle-invasive bladder cancerHTG522
Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroidsHTG523
Motor neurone disease: assessment and managementNG42
Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritisHTG521
Bisphosphonates for treating osteoporosisTA464
Long-acting reversible contraceptionCG30
Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormalityTA322
Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapiesTA171
Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomibTA586
Lenalidomide plus dexamethasone for previously untreated multiple myelomaTA587
Valve-in-valve TAVI for aortic bioprosthetic valve dysfunctionHTG518
Reinforcement of a permanent stoma with a synthetic or biological mesh to prevent a parastomal herniaHTG519
Cardiac contractility modulation device implantation for heart failureHTG520
Depression in children and young people: identification and managementNG134
Urinary incontinence and pelvic organ prolapse in women: managementNG123
Ambu aScope4 Broncho for use in unexpected difficult airwaysHTG312
Ocrelizumab for treating primary progressive multiple sclerosisTA585
Percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVIHTG515
Percutaneous mechanical thrombectomy for acute deep vein thrombosis of the legHTG516
Bronchoscopic thermal vapour ablation for upper-lobe emphysemaHTG517
Endocuff Vision for assisting visualisation during colonoscopyHTG514
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetesTA583
Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancerTA584
The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central cathetersHTG368
Percutaneous mitral valve leaflet repair for mitral regurgitationHTG513
Therapeutic hypothermia for acute ischaemic strokeHTG511
Collagen paste for closing an anal fistulaHTG512
Hyperparathyroidism (primary): diagnosis, assessment and initial managementNG132
Inotersen for treating hereditary transthyretin amyloidosisHST9
Enzalutamide for hormone-relapsed non-metastatic prostate cancerTA580
Curos for preventing infections when using needleless connectorsHTG510
Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary careHTG508
Ulcerative colitis: managementNG130
Crohn's disease: managementNG129
Intrapartum care for women with existing medical conditions or obstetric complications and their babiesNG121
Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphomaTA577
Certolizumab pegol for treating moderate to severe plaque psoriasisTA574
Tildrakizumab for treating moderate to severe plaque psoriasisTA575
Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal)TA576

Results per page

  1. 10
  2. 25
  3. 50
  4. All